UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
California Water Service
CWT
$3.06B
| $9.28M | ﹤0.01% |
214,279
-25,833
| -11% | -$1.18M |
|
|
SUPV
3352
Grupo Supervielle
SUPV
$738M
| $9.28M | ﹤0.01% |
785,432
+218,039
| +38% | +$2.13M |
|
3353
Cadre Holdings
CDRE
$1.41B
| $9.28M | ﹤0.01% |
227,152
-195,438
| -46% | -$8.13M |
|
|
RMT
3354
Royce Micro-Cap Trust
RMT
$762M
| $9.27M | ﹤0.01% |
888,800
-155,076
| -15% | -$1.61M |
|
3355
Eldorado Gold
EGO
$10B
| $9.26M | ﹤0.01% |
257,858
+113,710
| +79% | +$3.4M |
|
|
JBS
3356
JBS N.V.
JBS
$45.4B
| $9.25M | ﹤0.01% |
641,345
-2,047
| -0.3% | -$28.1K |
|
3357
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.85B
| $9.24M | ﹤0.01% |
257,310
+4,434
| +2% | +$157K |
|
3358
Highwoods Properties
HIW
$3.4B
| $9.23M | ﹤0.01% |
357,300
-166,720
| -32% | -$4.7M |
|
3359
Disc Medicine
IRON
$2.98B
| $9.22M | ﹤0.01% |
116,112
-55,511
| -32% | -$4.69M |
|
3360
iShares Morningstar Small-Cap Value ETF
ISCV
$704M
| $9.21M | ﹤0.01% |
134,439
+15
| +0% | +$1.01K |
|
3361
Invesco Mortgage Capital
IVR
$798M
| $9.2M | ﹤0.01% |
1,094,468
+446,017
| +69% | +$3.5M |
|
3362
Nuveen Churchill Direct Lending
NCDL
$620M
| $9.19M | ﹤0.01% |
689,050
+196,956
| +40% | +$2.8M |
|
3363
CALL
Regeneron Pharmaceuticals
REGN
$81.9B
| $9.19M | ﹤0.01% |
11,900
-4,600
| -28% | -$3.12M |
|
3364
Tandem Diabetes Care
TNDM
$1.55B
| $9.18M | ﹤0.01% |
417,833
-1,086,544
| -72% | -$19.6M |
|
3365
Nuveen ESG Mid-Cap Growth ETF
NUMG
$368M
| $9.18M | ﹤0.01% |
192,331
-12,413
| -6% | -$595K |
|
3366
WisdomTree US High Dividend Fund
DHS
$1.57B
| $9.16M | ﹤0.01% |
90,006
-4,241
| -4% | -$427K |
|
3367
Babcock & Wilcox
BW
$1.36B
| $9.16M | ﹤0.01% |
1,445,218
+1,183,893
| +453% | +$5.84M |
|
3368
iShares Convertible Bond ETF
ICVT
$7.46B
| $9.16M | ﹤0.01% |
93,022
+5,092
| +6% | +$512K |
|
3369
Invesco Semiconductors ETF
PSI
$2.49B
| $9.16M | ﹤0.01% |
116,174
-12,018
| -9% | -$918K |
|
3370
CVR Partners
UAN
$1.25B
| $9.16M | ﹤0.01% |
89,380
-5,694
| -6% | -$542K |
|
3371
Pricesmart
PSMT
$5.46B
| $9.16M | ﹤0.01% |
74,679
-51,379
| -41% | -$6.27M |
|
|
DFTX
3372
Definium Therapeutics
DFTX
$5.94B
| $9.16M | ﹤0.01% |
683,802
+131,993
| +24% | +$1.63M |
|
3373
First Bancorp
FBNC
$2.67B
| $9.15M | ﹤0.01% |
180,212
-53,025
| -23% | -$2.69M |
|
3374
PUT
HP
HPQ
$27.5B
| $9.13M | ﹤0.01% |
409,700
-369,100
| -47% | -$9.41M |
|
3375
Capital Group Core Bond ETF
CGCB
$5.77B
| $9.13M | ﹤0.01% |
344,151
+133,670
| +64% | +$3.56M |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.